{
    "ticker": "PASG",
    "info": {
        "address1": "One Commerce Square",
        "address2": "39th Floor 2005 Market Street",
        "city": "Philadelphia",
        "state": "PA",
        "zip": "19103",
        "country": "United States",
        "phone": "267 866 0311",
        "website": "https://www.passagebio.com",
        "industry": "Biotechnology",
        "industryKey": "biotechnology",
        "industryDisp": "Biotechnology",
        "sector": "Healthcare",
        "sectorKey": "healthcare",
        "sectorDisp": "Healthcare",
        "longBusinessSummary": "Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding \u00df-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.",
        "fullTimeEmployees": 58,
        "companyOfficers": [
            {
                "maxAge": 1,
                "name": "Dr. William  Chou M.D.",
                "age": 50,
                "title": "President, CEO & Director",
                "yearBorn": 1973,
                "fiscalYear": 2023,
                "totalPay": 945731,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Edgar B. Cale Esq., J.D.",
                "age": 59,
                "title": "General Counsel & Company Secretary",
                "yearBorn": 1964,
                "fiscalYear": 2023,
                "totalPay": 804692,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. James M. Wilson M.D., Ph.D.",
                "age": 68,
                "title": "Co-Founder & Chief Scientific Advisor",
                "yearBorn": 1955,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Ms. Kathleen  Borthwick",
                "age": 46,
                "title": "Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer",
                "yearBorn": 1977,
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Stuart M. Henderson",
                "title": "Senior Vice President of Corporate Development & Investor Relations",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Eden  Fucci",
                "title": "Senior Vice President of Technical Operations",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Sue  Browne Ph.D.",
                "title": "Senior Vice President of Research & Development",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Karl  Whitney Ph.D.",
                "title": "Senior Vice President of Global Regulatory Affairs",
                "fiscalYear": 2023,
                "exercisedValue": 0,
                "unexercisedValue": 0
            }
        ],
        "auditRisk": 3,
        "boardRisk": 5,
        "compensationRisk": 8,
        "shareHolderRightsRisk": 8,
        "overallRisk": 6,
        "governanceEpochDate": 1730073600,
        "compensationAsOfEpochDate": 1703980800,
        "maxAge": 86400,
        "priceHint": 4,
        "previousClose": 0.6372,
        "open": 0.6203,
        "dayLow": 0.61,
        "dayHigh": 0.6576,
        "regularMarketPreviousClose": 0.6372,
        "regularMarketOpen": 0.6203,
        "regularMarketDayLow": 0.61,
        "regularMarketDayHigh": 0.6576,
        "beta": 1.188,
        "forwardPE": -1.2472,
        "volume": 189067,
        "regularMarketVolume": 189067,
        "averageVolume": 302309,
        "averageVolume10days": 267120,
        "averageDailyVolume10Day": 267120,
        "bid": 0.5957,
        "ask": 0.6589,
        "bidSize": 100,
        "askSize": 100,
        "marketCap": 38666320,
        "fiftyTwoWeekLow": 0.54,
        "fiftyTwoWeekHigh": 1.79,
        "fiftyDayAverage": 0.6692,
        "twoHundredDayAverage": 1.025895,
        "currency": "USD",
        "enterpriseValue": -27103920,
        "floatShares": 37096197,
        "sharesOutstanding": 61767300,
        "sharesShort": 1682395,
        "sharesShortPriorMonth": 1786321,
        "sharesShortPreviousMonthDate": 1726185600,
        "dateShortInterest": 1728950400,
        "sharesPercentSharesOut": 0.0272,
        "heldPercentInsiders": 0.00487,
        "heldPercentInstitutions": 0.60427,
        "shortRatio": 6.41,
        "shortPercentOfFloat": 0.0327,
        "impliedSharesOutstanding": 62005000,
        "bookValue": 1.466,
        "priceToBook": 0.4253752,
        "lastFiscalYearEnd": 1703980800,
        "nextFiscalYearEnd": 1735603200,
        "mostRecentQuarter": 1719705600,
        "netIncomeToCommon": -76570000,
        "trailingEps": -1.34,
        "forwardEps": -0.5,
        "enterpriseToEbitda": 0.32,
        "52WeekChange": -0.010869563,
        "SandP52WeekChange": 0.3763833,
        "exchange": "NMS",
        "quoteType": "EQUITY",
        "symbol": "PASG",
        "underlyingSymbol": "PASG",
        "shortName": "Passage Bio, Inc.",
        "longName": "Passage Bio, Inc.",
        "firstTradeDateEpochUtc": 1582900200,
        "timeZoneFullName": "America/New_York",
        "timeZoneShortName": "EDT",
        "uuid": "f9f4ff21-d010-3b23-9d8c-0b97242aa032",
        "messageBoardId": "finmb_602462727",
        "gmtOffSetMilliseconds": -14400000,
        "currentPrice": 0.6236,
        "targetHighPrice": 13.0,
        "targetLowPrice": 3.0,
        "targetMeanPrice": 6.75,
        "targetMedianPrice": 5.5,
        "recommendationMean": 1.6,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 4,
        "totalCash": 91773000,
        "totalCashPerShare": 1.486,
        "ebitda": -84650000,
        "totalDebt": 26151000,
        "quickRatio": 7.41,
        "currentRatio": 7.671,
        "debtToEquity": 28.878,
        "returnOnAssets": -0.3448,
        "returnOnEquity": -0.63550997,
        "freeCashflow": -53035248,
        "operatingCashflow": -70744000,
        "financialCurrency": "USD",
        "trailingPegRatio": null
    }
}